首页> 中文期刊> 《中华医学杂志:英文版》 >Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma: an open-label,observational, multi-center study in China

Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma: an open-label,observational, multi-center study in China

         

著录项

  • 来源
    《中华医学杂志:英文版》 |2011年第19期|P.2969-2974|共6页
  • 作者单位

    ^pof;

    Hematology,;

    Shanghai;

    Changzheng;

    Hospital,Second;

    Military;

    Medical;

    University,;

    Shanghai;

    200003,;

    China;

    ^pof;

    Hematology,;

    First;

    Affiliated;

    Hospital,;

    Medical;

    School;

    of;

    Zhejiang;

    University,;

    Hangzhou,;

    Zhejiang;

    310006,;

    China;

    ^pof;

    Hematology,;

    People's;

    Hospital,;

    Peking;

    University,Beijing;

    100044,;

    China;

    ^pof;

    Hematology,;

    First;

    Hospital,;

    China;

    Medical;

    University,;

    Shenyang,;

    Liaoning;

    110001,;

    China;

    ^pof;

    Hematology,;

    Beijing;

    Chaoyang;

    Hospital,;

    Beijing100020,;

    China;

    ^pof;

    Hematology,;

    Shengjing;

    Hospital,;

    China;

    Medical;

    University,;

    Shenyang,;

    Liaoning;

    110004,;

    China;

    ^pof;

    Hematology,;

    Xijing;

    Hospital,;

    Fourth;

    Military;

    Medical;

    University,;

    Xi'an,;

    Shaanxi;

    710032,;

    China;

    ^pof;

    Hematology,;

    Ruijin;

    Hospital,;

    Shanghai;

    Jiao;

    Tong;

    University;

    School;

    of;

    Medicine,;

    Shanghai;

    200025,;

    China;

  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 S858.237.2;
  • 关键词

    多发性骨髓瘤; 地塞米松; 最佳剂量; 多中心; 治疗; 中国; 复发; 标签;

    机译:多发性骨髓瘤;地塞米松;最佳剂量;多中心;治疗;中国;复发;标签;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号